Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryopreserved vs Liquid Stored Platelets in Cardiac Surgery
NCT04709705Phase 3Completed
- Sponsor
- Cellphire Therapeutics, Inc.
- Start
- Oct 2021
- Primary completion
- May 2025
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cryopreserved platelets (2 arms), sponsored by Cellphire Therapeutics, Inc. Primary endpoint: Blood Loss at 24 hours. Started Oct 2021; status: completed.
02
Drugs
cryopreserved platelets
Beyond the preview
Go deeper on NCT04709705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04709705.